MedTrace Logo

Adjunctive Game Intervention for Anhedonia in MDD Patients

NCT04977232 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-08-21

No results posted yet for this study

Summary

This is a pilot study using game intervention as an adjuvant treatment, to evaluate the effect of the video game on anhedonia and associated functional change of brain in patients with depression. Participants will be randomized to Experimental group receiving a 8-week treatment of antidepressant drugs and game intervention, or Control group receiving a 8-week treatment of antidepressant drugs. Magnetic resonance imaging scanning and assessment of clinical characteristics and cognitive function were conducted before and after the intervention.

Conditions

Interventions

DRUG

Escitalopram

Selective serotonin reuptake inhibitors (SSRI) were most commonly used first line pharmacotherapy for depression.

BEHAVIORAL

Game intervention

Participants will be instructed to play the commercial video game for about 30-60 minutes at least three times per week.

Sponsors & Collaborators

  • Central South University

    lead OTHER

Principal Investigators

  • Wenbin Guo · Central South University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-09
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04977232 on ClinicalTrials.gov